Kestra Medical Technologies (KMTS) Latest Stock Analysis Report – Oct 15, 2026, 4:00 PM ET
Updated Oct 15, 2026, 4:00 PM ET
- Closed at $28.68, +12.60% vs the prior close of $25.47.
- Volume 405.50K shares, 1.2x its 50-day average.
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
KMTS jumps 12.6% to $28.68, a 52-week high. Closed at $28.68, +12.60% vs the prior close of $25.47. Day range $25.66–$28.78, opened at $25.68.
KMTS daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 15, 2026 — KMTS jumps 12.6% to $28.68, a 52-week high
- Closed at $28.68, +12.60% vs the prior close of $25.47. Day range $25.66–$28.78, opened at $25.68.
- Volume was 405.50K shares, 1.2x its 50-day average of 330.29K.
- Price is +8.8% vs its 50-day average ($26.37) and +21.6% vs its 200-day average ($23.59).
- 52-week range $17.34–$30.00; today's close sits at 90% of that range, 4.4% below the 52-week high.
Oct 14, 2026 — KMTS slides 5.6% to $25.47
- Closed at $25.47, -5.56% vs the prior close of $26.97. Day range $25.39–$26.72, opened at $26.45.
- Volume was 237.40K shares, 0.7x its 50-day average of 340.17K.
- Price is -3.1% vs its 50-day average ($26.29) and +8.0% vs its 200-day average ($23.58).
- 52-week range $17.34–$30.00; today's close sits at 64% of that range, 15.1% below the 52-week high.
Oct 13, 2026 — KMTS ends flat (+0.2%) to $26.97
- Closed at $26.97, +0.22% vs the prior close of $26.91. Day range $26.43–$27.27, opened at $27.00.
- Volume was 131.10K shares, 0.4x its 50-day average of 345.02K — lighter than usual.
- Price is +2.5% vs its 50-day average ($26.30) and +14.4% vs its 200-day average ($23.58).
- 52-week range $17.34–$30.00; today's close sits at 76% of that range, 10.1% below the 52-week high.
Oct 12, 2026 — KMTS ends flat (-0.3%) to $26.91
- Closed at $26.91, -0.26% vs the prior close of $26.98. Day range $26.30–$27.20, opened at $27.02.
- Volume was 131.00K shares, 0.4x its 50-day average of 347.96K — lighter than usual.
- Price is +2.5% vs its 50-day average ($26.24) and +14.1% vs its 200-day average ($23.59).
- 52-week range $17.34–$30.00; today's close sits at 76% of that range, 10.3% below the 52-week high.
Oct 9, 2026 — KMTS jumps 4.7% to $26.98
- Closed at $26.98, +4.70% vs the prior close of $25.77. Day range $25.74–$27.13, opened at $25.74.
- Volume was 246.80K shares, 0.7x its 50-day average of 348.70K.
- Price is +3.1% vs its 50-day average ($26.16) and +14.4% vs its 200-day average ($23.59).
- 52-week range $17.34–$30.00; today's close sits at 76% of that range, 10.1% below the 52-week high.
Oct 8, 2026 — KMTS dips 2.7% to $25.77, 3 down days in a row
- Closed at $25.77, -2.72% vs the prior close of $26.49. Day range $25.25–$26.17, opened at $26.17.
- Volume was 379.70K shares, 1.1x its 50-day average of 347.43K.
- Price is -1.2% vs its 50-day average ($26.09) and +9.2% vs its 200-day average ($23.59).
- 52-week range $17.34–$30.00; today's close sits at 67% of that range, 14.1% below the 52-week high.
- That makes 3 straight losses.
Oct 7, 2026 — KMTS dips 2.3% to $26.49
- Closed at $26.49, -2.25% vs the prior close of $27.10. Day range $25.90–$27.61, opened at $26.56.
- Volume was 399.50K shares, 1.1x its 50-day average of 348.46K.
- Price is +1.8% vs its 50-day average ($26.03) and +12.2% vs its 200-day average ($23.60).
- 52-week range $17.34–$30.00; today's close sits at 72% of that range, 11.7% below the 52-week high.
Oct 6, 2026 — KMTS slides 4.4% to $27.10
- Closed at $27.10, -4.38% vs the prior close of $28.34. Day range $27.06–$29.24, opened at $28.68.
- Volume was 262.30K shares, 0.8x its 50-day average of 347.13K.
- Price is +4.3% vs its 50-day average ($25.97) and +14.8% vs its 200-day average ($23.61).
- 52-week range $17.34–$30.00; today's close sits at 77% of that range, 9.7% below the 52-week high.
Oct 5, 2026 — KMTS jumps 3.3% to $28.34
- Closed at $28.34, +3.32% vs the prior close of $27.43. Day range $27.21–$28.44, opened at $27.64.
- Volume was 293.60K shares, 0.9x its 50-day average of 344.79K.
- Price is +9.5% vs its 50-day average ($25.89) and +20.1% vs its 200-day average ($23.60).
- 52-week range $17.34–$30.00; today's close sits at 87% of that range, 5.5% below the 52-week high.
Oct 2, 2026 — KMTS rises 1.2% to $27.43
- Closed at $27.43, +1.16% vs the prior close of $27.11. Day range $26.81–$27.83, opened at $27.52.
- Volume was 254.80K shares, 0.7x its 50-day average of 343.98K.
- Price is +6.6% vs its 50-day average ($25.74) and +16.2% vs its 200-day average ($23.60).
- 52-week range $17.34–$30.00; today's close sits at 80% of that range, 8.6% below the 52-week high.
KMTS latest news & SEC filings
Every SEC filing by or about KMTS in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Oct 1, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Cohen Raymond W sold 3,330 shares at $29.28 (≈$97.50K) on Sep 30, 2026; now holds 54,790
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Sep 30, 2026 · Form 144 — Planned insider sale
Notice of proposed sale (Form 144) — an insider or affiliate plans to sell restricted or control shares
A notice of intent, not a completed sale. Any actual sale by a director or officer shows up later on Form 4.
Sep 23, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Kwo Elizabeth sold 4,010 shares at $24.26 (≈$97.27K) on Sep 21, 2026; now holds 14,116
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Sep 21, 2026 · Form 144 — Planned insider sale
Notice of proposed sale (Form 144) — an insider or affiliate plans to sell restricted or control shares
A notice of intent, not a completed sale. Any actual sale by a director or officer shows up later on Form 4.
Sep 14, 2026 · Form 10-Q — Quarterly report
Quarterly report (unaudited financial statements for the quarter)
Quarter ended Jul 31, 2026:
- Revenue: $30.97M (prior year $19.37M) (+59.9% vs Jul 31, 2025)
- Net income: -$44.09M (prior year -$25.83M) (loss widened vs Jul 31, 2025)
- Diluted EPS: -$0.75 (prior year -$0.50) (loss widened vs Jul 31, 2025)
Sep 14, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 2.02 — Reported results of operations (earnings release).
This is a results-day filing: the earnings press release is attached as an exhibit.
Sep 10, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Schwartz Jeffrey Lawrence sold 3,890 shares at $25.18 (≈$97.95K) on Sep 8, 2026
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Sep 10, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Sep 10, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 5.07 — Reported shareholder vote results.
Aug 14, 2026 · Form SCHEDULE 13G/A — Update to a passive 5%+ stake (13G)
Update to a passive 5%+ stake (13G)
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Jul 28, 2026 · Form ARS — Annual report to shareholders
Annual report to shareholders
Jul 28, 2026 · Form DEFA14A — Additional proxy materials
Additional proxy materials
Jul 28, 2026 · Form DEF 14A — Proxy statement
Proxy statement — agenda for the shareholder meeting (board elections, executive pay, votes)
Jul 14, 2026 · Form 10-K — Annual report
Annual report (audited full-year financial statements and business review)
Fiscal year ended Apr 30, 2026:
- Revenue: $95.13M (prior year $59.81M) (+59.0% vs Apr 30, 2025)
- Net income: -$131.61M (prior year -$113.81M) (loss widened vs Apr 30, 2025)
- Diluted EPS: -$2.43 (prior year -$5.13) (loss narrowed vs Apr 30, 2025)
Jul 14, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 1.01 — Signed a material agreement.
- Item 1.02 — Ended a material agreement.
- Item 2.02 — Reported results of operations (earnings release).
- Item 2.03 — Took on a new material debt or financial obligation.
This is a results-day filing: the earnings press release is attached as an exhibit.
Things to know before you trade KMTS
- Last results release: Sep 14, 2026 (8-K Item 2.02). Previous ones: Jul 14, 2026, Mar 17, 2026, Dec 11, 2025. Based on that rhythm, the next report is likely around Dec 14, 2026 — an estimate, not a confirmed date.
- How much it moves: over the last 20 sessions the average daily move was 3.12% (largest 12.6%). That is a volatile stock.
- Liquidity: about 351.06K shares (≈$10.07M) trade per day on average.
- 52-week position: $28.68 vs a range of $17.34–$30.00 (90% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 0 open-market buys, 25 sales; latest: Elizabeth Kwo sold 4,010 shares on Sep 21, 2026.
- Latest filings: 10-Q Sep 14, 2026; 8-K Sep 14, 2026; 8-K Sep 10, 2026.
- Share count: 59.56M shares outstanding (Sep 11, 2026), +15.8% vs a year earlier — notable dilution.
- Listing: Nasdaq · industry: Surgical & Medical Instruments & Apparatus.
KMTS market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 15, 2026 | 25.68 | 28.78 | 25.66 | 28.68 | 405.50K |
| Oct 14, 2026 | 26.45 | 26.72 | 25.39 | 25.47 | 237.40K |
| Oct 13, 2026 | 27.00 | 27.27 | 26.43 | 26.97 | 131.10K |
| Oct 12, 2026 | 27.02 | 27.20 | 26.30 | 26.91 | 131.00K |
| Oct 9, 2026 | 25.74 | 27.13 | 25.74 | 26.98 | 246.80K |
| Oct 8, 2026 | 26.17 | 26.17 | 25.25 | 25.77 | 379.70K |
| Oct 7, 2026 | 26.56 | 27.61 | 25.90 | 26.49 | 399.50K |
| Oct 6, 2026 | 28.68 | 29.24 | 27.06 | 27.10 | 262.30K |
| Oct 5, 2026 | 27.64 | 28.44 | 27.21 | 28.34 | 293.60K |
| Oct 2, 2026 | 27.52 | 27.83 | 26.81 | 27.43 | 254.80K |
| Oct 1, 2026 | 28.14 | 29.66 | 26.97 | 27.11 | 371.40K |
| Sep 30, 2026 | 28.46 | 29.58 | 28.17 | 28.29 | 616.80K |
| Sep 29, 2026 | 28.48 | 28.95 | 27.83 | 28.46 | 455.00K |
| Sep 28, 2026 | 27.04 | 28.43 | 26.88 | 28.13 | 292.90K |
| Sep 25, 2026 | 26.02 | 27.68 | 25.57 | 27.14 | 339.70K |
| Sep 24, 2026 | 25.45 | 26.00 | 25.24 | 25.76 | 306.10K |
| Sep 23, 2026 | 26.03 | 26.06 | 25.14 | 25.51 | 222.70K |
| Sep 22, 2026 | 25.16 | 26.11 | 24.75 | 26.09 | 281.60K |
| Sep 21, 2026 | 24.69 | 24.88 | 24.14 | 24.77 | 144.10K |
| Sep 18, 2026 | 24.35 | 25.08 | 24.29 | 24.43 | 1.25M |
About Kestra Medical Technologies
Kestra Medical Technologies (KMTS) is listed on the Nasdaq and classified by the SEC under “Surgical & Medical Instruments & Apparatus”. Its business address is in KIRKLAND, WA. State of incorporation: Bermuda. Fiscal year ends April 30. SEC CIK 1877184.
KMTS board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Raymond W Cohen | Director | Sep 10, 2026 |
| Conor Hanley | Director | Sep 10, 2026 |
| Elizabeth Kwo | Director | Sep 23, 2026 |
| Mary Kay Ladone | Director | Sep 10, 2026 |
| Kevin C Reilly | Director | Sep 10, 2026 |
| Jeffrey Lawrence Schwartz | Director | Sep 10, 2026 |
| Traci S Umberger | See Remarks | Aug 6, 2026 |
| Brian Daniel Webster | See Remarks | Aug 18, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Alfred J Jr Ford | Chief Commercial Officer | Aug 6, 2026 |
| Vaseem Mahboob | Chief Financial Officer | Aug 11, 2026 |
| Timothy P. Moran | Chief Business Officer | Aug 3, 2026 |
| Traci S Umberger | See Remarks | Aug 6, 2026 |
| Brian Daniel Webster | See Remarks | Aug 18, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Sep 21, 2026 | Elizabeth Kwo | Sale | 4,010 | $24.26 |
| Sep 8, 2026 | Kevin C Reilly | Sale | 2,932 | $25.13 |
| Sep 8, 2026 | Mary Kay Ladone | Sale | 3,908 | $25.20 |
| Sep 8, 2026 | Jeffrey Lawrence Schwartz | Sale | 3,890 | $25.18 |
| Sep 8, 2026 | Conor Hanley | Sale | 5,694 | $25.25 |
| Aug 17, 2026 | Brian Daniel Webster | Sale | 15,000 | $27.48 |
| Aug 7, 2026 | Vaseem Mahboob | Sale | 500 | $26.33 |
| Aug 7, 2026 | Vaseem Mahboob | Sale | 25,787 | $25.87 |
| Aug 4, 2026 | Vaseem Mahboob | Sale | 3,915 | $25.17 |
| Aug 4, 2026 | Vaseem Mahboob | Sale | 3,080 | $24.06 |
| Aug 4, 2026 | Brian Daniel Webster | Sale | 48,625 | $24.47 |
| Aug 4, 2026 | Brian Daniel Webster | Sale | 442 | $25.98 |
| Aug 4, 2026 | Brian Daniel Webster | Sale | 2,833 | $25.16 |
| Aug 4, 2026 | Alfred J Jr Ford | Sale | 6,275 | $24.09 |
| Aug 4, 2026 | Traci S Umberger | Sale | 3,580 | $24.04 |
KMTS financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Apr 30, 2026 | $95.13M | $-131.61M | -2.43 | $-81.70M |
| Apr 30, 2025 | $59.81M | $-113.81M | -5.13 | $-77.61M |
| Apr 30, 2024 | $27.81M | $-94.12M | -5.07 | $-72.23M |
Latest balance sheet: total assets $347.36M, total liabilities $125.00M, cash $68.56M (as of Jul 31, 2026).
KMTS earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| Sep 14, 2026 | 8-K Item 2.02 (results) | $24.06 |
| Jul 14, 2026 | 8-K Item 2.02 (results) | $24.18 |
| Mar 17, 2026 | 8-K Item 2.02 (results) | $21.14 |
| Dec 11, 2025 | 8-K Item 2.02 (results) | $24.91 |
| Dec 1, 2025 | 8-K Item 2.02 (results) | $24.69 |
| Sep 11, 2025 | 8-K Item 2.02 (results) | $18.40 |
| Jul 15, 2025 | 8-K Item 2.02 (results) | $16.29 |
| Apr 14, 2025 | 8-K Item 2.02 (results) | $23.83 |
Related stocks · Surgical & Medical Instruments & Apparatus
Stryker (SYK)Boston Scientific (BSX)3M (MMM)MiniMed (MMED)Dexcom (DXCM)Becton Dickinson (BDX)Medline (MDLN)Resmed (RMD)Insulet (PODD)West Pharmaceutical Services (WST)
Popular today
Micron Technology (MU)Spdr S&P 500 Etf (SPY)Nvidia (NVDA)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Intel (INTC)Apple (AAPL)Microsoft (MSFT)Meta Platforms (META)Broadcom (AVGO)Tesla (TSLA)
More on KMTS
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 15, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.